Evidence map›Paper›PMID 40730500›Full record

ArticleJournal of microbiology and biotechnology2025

Effect of Particulate Matter in Atopic Dermatitis through HDACs and Filaggrin Alteration.

Yoon Jin Roh, Kui Young Park, Na Yeon Koo, Yong Hee Choi, Hye Won Song, Sin Woo Sung, Ka Ram Kim, Seong Jun Seo, Joon Seok, Mi-Kyung Lee

Abstract read
In one paragraph

Article in Journal of microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yoon Jin RohDepartment of Dermatology, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
Kui Young ParkDepartment of Dermatology, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
Na Yeon KooDepartment of Dermatology, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
Yong Hee ChoiDepartment of Dermatology, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
Hye Won SongDepartment of Dermatology, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
Sin Woo SungDepartment of Dermatology, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
Ka Ram KimDepartment of Dermatology, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
Seong Jun SeoDepartment of Dermatology, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
Joon SeokDepartment of Dermatology, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
Mi-Kyung LeeDepartment of Laboratory Medicine, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic dermatitis (AD) is a skin condition that can be exacerbated by particulate matter (PM). The primary causes of AD are believed to be impairments in the skin barrier, such as filaggrin (FLG) abnormalities. Although there is substantial evidence for genetic factors contributing to AD, it is challenging to attribute the disease's predisposition solely to genetics. We hypothesize that PM may induce epigenetic modifications in AD, impacting FLG expression. Here, we assessed histone deacetylases (HDACs) and FLG levels under AD conditions with or without exposure to PM using qRT-PCR, western blotting, and immunofluorescence. Additionally, we observed changes in these molecules when co-treated with the HDAC inhibitor, trichostatin A (TSA). FLG levels tended to decrease when PM or IL-4/13 were given individually, and a further decrease upon IL-4/13 and PM cotreatment. Interestingly, HDAC3 and HDAC6 are increased when they were both given PM10 and IL-4/13 co-treatment compared to IL-4/13 treatment alone. FLG levels exhibited a significant restoration and the levels of HDACs were changed when treated with TSA than with IL-4/13 or IL-4/13+PM co-treatment. We found changes in FLG and HDACs in the AD-like in vivo model and in this model with PM. Our findings suggest that PM can induce epigenetic alterations in AD. Treatment with TSA ameliorates these effects on FLG expression, indicating its potential as a novel therapeutic approach for AD.

Indexed as

Dermatitis, AtopicHistone DeacetylasesIntermediate Filament ProteinsParticulate MatterAnimalsEpigenesis, GeneticFilaggrin ProteinsHistone Deacetylase InhibitorsHumansHydroxamic AcidsInterleukin-4SkinFilaggrin ProteinsFLG protein, humanHistone Deacetylase InhibitorsHistone DeacetylasesHydroxamic AcidsInterleukin-4Intermediate Filament ProteinsParticulate Mattertrichostatin AAtopic dermatitisfilaggrinhistone deacetylationparticle mattertrichostatin A

Identifiers

PMID40730500
PMCPMC12324990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.